Inhibrx Biosciences Inc.
INBX | NASDAQ
$115.23
+$3.19 (+2.85%)
Sep 22, 2026, 10:52 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -36.65M | -33.44M | -32.83M | -35.26M | -28.65M | -43.31M | -47.87M | -43.86M | 1.83B | -78.71M | -7.21M | -51.79M | -56.36M | -39.61M | -40.92M | -35.33M | -37.73M | -31.25M | -21.19M | -20.58M | -20.71M | -19.29M |
Depreciation & Amortization | 523K | 537K | 564K | 583K | 661K | 675K | 689K | 760K | 475K | 360K | 298K | 304K | 294K | 295K | 302K | 309K | 307K | 307K | 307K | 299K | 298K | 291K |
Stock-Based Compensation | 3.1M | 2.65M | 2.74M | 3.18M | 2.77M | 2.45M | 2.98M | 2.97M | 47.53M | 6.4M | 2.27M | 6.53M | 7.2M | 4.69M | 5.36M | 4.69M | 5.3M | 5.11M | 4.18M | 3.49M | 3.95M | 3.42M |
Other Working Capital | -718K | -11.8M | -1.55M | -2.03M | -4.45M | 3.47M | 2.42M | 9.55M | 18.07M | 3.76M | 11.51M | -9.38M | -4.81M | 2.06M | 2.96M | -983K | 2.52M | -743K | 939K | -508K | -818K | 387K |
Other Non-Cash Items | 2.81M | 1.22M | 1.12M | 1.1M | 1.07M | 967K | 470K | 498K | -1.97B | 1.71M | -3.2M | 1.69M | 2.85M | 429K | 1.68M | 1.44M | 1.07M | 902K | -3.36M | 776K | 602K | 563K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -9K | n/a |
Change in Working Capital | 293K | -8.99M | -1.72M | -3.42M | -5.8M | 3.32M | 4K | 9.36M | 35.49M | 7.2M | 15.31M | -10.98M | -9.29M | 7.26M | 2.98M | -1.95M | 4.14M | -2M | -2.56M | 2.34M | -6.51M | -6.63M |
Operating Cash Flow | -29.92M | -38.03M | -30.12M | -33.82M | -29.95M | -35.9M | -43.72M | -30.28M | -57.36M | -63.05M | 7.48M | -54.25M | -55.3M | -26.94M | -30.6M | -30.84M | -26.92M | -26.94M | -22.62M | -13.68M | -22.38M | -21.65M |
Capital Expenditures | 27K | n/a | n/a | -10K | n/a | -21K | -16K | -247K | -1.22M | -1.12M | -3.44M | -811K | -317K | -23K | -267K | 20K | -322K | -117K | -267K | -169K | -414K | -14K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | 3K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 55K | n/a |
Investing Cash Flow | 27K | n/a | n/a | -7K | n/a | -21K | -16K | -247K | -1.22M | -1.12M | -3.44M | -811K | -317K | -23K | -267K | 20K | -322K | -117K | -267K | -169K | -359K | -14K |
Debt Repayment | n/a | 74.99M | n/a | n/a | n/a | 99.97M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | 352K | n/a | -125K | n/a | n/a | n/a | n/a | -67.5M | 199.89M | -25.75M | 26.61M | 158.66M | 506K | 60.16M | 39.22M | 41.48M | 820K | 40.48M | 988K |
Financial Cash Flow | 1.6M | 75.46M | 1.25M | 352K | n/a | 99.84M | n/a | n/a | 32.95M | 38.73M | -67.5M | 199.89M | -25.75M | 26.96M | 158.66M | 506K | 60.16M | 39.22M | 41.48M | 820K | 40.48M | 988K |
Net Cash Flow | -28.31M | 37.44M | -28.87M | -33.48M | -29.95M | 63.92M | -43.74M | -30.53M | -25.62M | -25.44M | -337.33M | 144.84M | 192.49M | -39.61M | 127.79M | -30.31M | 32.92M | 12.17M | 18.6M | -13.02M | 17.74M | -20.67M |
Free Cash Flow | -29.89M | -38.03M | -30.12M | -33.83M | -29.95M | -35.92M | -43.74M | -30.53M | -58.57M | -64.17M | 4.04M | -55.06M | -55.62M | -26.96M | -30.87M | -30.82M | -27.24M | -27.06M | -22.89M | -13.84M | -22.79M | -21.66M |
Adj. Free Cash Flow | -32.99M | -40.68M | -32.87M | -37.01M | -32.72M | -38.37M | -46.72M | -33.49M | -106.1M | -70.57M | 1.77M | -61.59M | -62.82M | -31.65M | -36.22M | -35.51M | -32.54M | -32.17M | -27.07M | -17.34M | -26.75M | -25.08M |
Maintenance CapEx | -27K | n/a | n/a | -10K | n/a | -21K | -16K | -247K | -1.11M | -1.12M | -2.02M | -811K | -317K | -23K | -267K | 20K | -322K | -75.4K | -225.22K | -169K | -414K | -14K |
Growth CapEx | 54K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -107.24K | n/a | -1.42M | n/a | n/a | n/a | n/a | n/a | n/a | -41.6K | -41.78K | n/a | n/a | n/a |
Owner Earnings | -29.94M | -38.03M | -30.12M | -33.83M | -29.95M | -35.92M | -43.74M | -30.53M | -58.47M | -64.17M | 5.46M | -55.06M | -55.62M | -26.96M | -30.87M | -30.82M | -27.24M | -27.02M | -22.85M | -13.84M | -22.79M | -21.66M |
Add to Watchlist
Select watchlists to add or remove INBX